Polyunsaturated fatty acids in hyperlipoproteinemia. II. Administration of essential phospholipids in hypertriglyceridemia.
D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol / Q000032:analysis; D004041:Dietary Fats; D005227:Fatty Acids / Q000032:analysis*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood*; D008041:Linoleic Acids / Q000494:pharmacology; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000494:pharmacology*; D010743:Phospholipids / Q000032:analysis; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
D004041:Dietary Fats; D005227:Fatty Acids; D008041:Linoleic Acids; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010713:Phosphatidylcholines; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol